According to the research report titled, ‘Onychomycosis Treatment Market Size By Test (Distal Subungual Onychomycosis (DSO), White Superficial Onychomycosis (WSO), Proximal Subungual Onychomycosis (PSO), Candida Onychomycosis), By Treatment Type (Drug Treatment, Topical Therapy), By Drug Class (Allylamine, Azole, Griseofulvin), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027,’ available with MarketStudyReport, global onychomycosis treatment market is anticipated to register substantial gains during 2021-2027.
 

Increasing consumer demand in leading regions and advanced research focus on development of more effective treatment methods are propelling the growth of global onychomycosis treatment market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4202304/
 

For the unversed, onychomycosis is a type of infection in the nails which is caused by certain type of microorganisms.
 

In addition, surging prevalence of diabetes, growing incidence of onychomycosis in adults and geriatric population, as well as surging cognizance about the potential threat of this disease are augmenting the industry outlook.
 

On the contrary, side effects associated with the use of treatment drugs is likely to impede market progression in the ensuing years.
 

Based on test type, white superficial onychomycosis segment captured 13.9% market share in 2020 and is expected to expand substantially through 2027, owing to surge in the number of white superficial onychomycosis cases.
 

In terms of treatment type segmentation of global onychomycosis treatment market, topical therapy segment held a market share of 40% in 2020 and is slated to showcase lucrative expansion trends over the study period, propelled by the rising availability of several topical solutions.
 

By drug class, the azoles segment held 17% market share in 2020 and is poised to amass notable returns through 2027, which is driven by increasing awareness about advantages of azole drugs.
 

On the basis of distribution channel, online pharmacies segment was worth USD 462 million in 2020 and is expected to register substantial gains through 2027, due to growing consumer preference for purchasing medicines via online pharmacies.
 

Regionally speaking, Latin America market exceeded a valuation of USD 120 million in 2020 and is projected to exhibit lucrative growth trends during 2021-2027, accreditable to enhanced healthcare infrastructure across the region.